Ozen Pick subcutaneous injection 0.25 mg SD (YJ code: 2499418G1028, standard: 0.25mg 0.5mL 1 kit), manufactured by Novo Nordisk Pharma, contains semaglutide (genetical recombination). This GLP-1 receptor agonist is used to improve glycemic control in adults with type 2 diabetes and may also aid in weight loss by reducing appetite and slowing digestion.
Ozen Pick subcutaneous injection 0.25 mg SD
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).